Assembly and entry mechanisms of Semliki Forest virus. 1994

H Garoff, and J Wilschut, and P Liljeström, and J M Wahlberg, and R Bron, and M Suomalainen, and J Smyth, and A Salminen, and B U Barth, and H Zhao
Department of Molecular Biology, Huddinge, Sweden.

The alphavirus Semliki Forest (SFV) is an enveloped virus with a positive single-stranded RNA genome. The genome is complexed with 240 copies of a capsid protein into a nucleocapsid structure. In the membrane the virus carries an equal number of copies of a membrane protein heterodimer. The latter oligomers are grouped into clusters of three. These structures form the spikes of the virus and carry its entry functions, that is receptor binding and membrane fusion activity. The membrane protein heterodimer is synthesized as a p62E1 precursor protein which upon transport to the cell surface is cleaved into the mature E2E1 form. Recent studies have given much new information on the assembly and entry mechanism of this simple RNA virus. Much of this work has been possible through the construction of a complete cDNA clone of the SFV genome which can be used for in vitro transcription of infectious RNA. One important finding has been to show that a spike deletion variant and a capsid protein deletion variant are budding-negative when expressed separately but can easily complement each other when transfected into the same cell. This shows clearly that enveloped viruses use different budding strategies: one which depends on a nucleocapsid-spike interaction as exemplified by SFV and another one which is based on a direct core-lipid bilayer interaction as shown before to be the case with retroviruses. Another important finding concerns the activation process of the presumed fusion protein of SFV, the E1 subunit. In the original p62E1 heterodimer E1 is completely inactive. Activation proceeds in several steps. First p62 cleavage activates the potential for low pH inducible fusion. Next the low pH which surrounds incoming virus in endosomes induces dissociation of the heterodimeric structure. This is followed by a rearrangement of E1 subunits into homotrimers which are fusion active.

UI MeSH Term Description Entries
D002213 Capsid The outer protein protective shell of a virus, which protects the viral nucleic acid. Capsids are composed of repeating units (capsomers or capsomeres) of CAPSID PROTEINS which when assembled together form either an icosahedral or helical shape. Procapsid,Prohead,Capsids,Procapsids,Proheads
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D012672 Semliki forest virus A species of ALPHAVIRUS isolated in central, eastern, and southern Africa.
D014758 Viral Core Proteins Proteins found mainly in icosahedral DNA and RNA viruses. They consist of proteins directly associated with the nucleic acid inside the NUCLEOCAPSID. Core Proteins, Viral,Major Core Protein,Major Core Proteins, Viral,Adenovirus Core Protein VII,Core Protein V,Core Protein lambda 2,Influenza Virus Core Proteins,Major Core Protein lambda 1,Major Core Protein lambda-1,Major Core Protein sigma 2,Major Core Protein sigma-2,OVP 19,Oncornaviral Protein P19,P30 Core Proteins,Viral Protein P19,Virus Core Proteins,Core Protein, Major,Core Proteins, P30,Core Proteins, Virus,Protein P19, Oncornaviral,Protein P19, Viral,Protein, Major Core,Proteins, P30 Core,Proteins, Viral Core,Proteins, Virus Core
D014759 Viral Envelope Proteins Integral membrane proteins that are incorporated into the VIRAL ENVELOPE. They are glycosylated during VIRAL ASSEMBLY. Envelope Proteins, Viral,Viral Envelope Glycoproteins,Viral Envelope Protein,Virus Envelope Protein,Virus Peplomer Proteins,Bovine Leukemia Virus Glycoprotein gp51,Hepatitis Virus (MHV) Glycoprotein E2,LaCrosse Virus Envelope Glycoprotein G1,Simian Sarcoma Virus Glycoprotein 70,Viral Envelope Glycoprotein gPr90 (Murine Leukemia Virus),Viral Envelope Glycoprotein gp55 (Friend Virus),Viral Envelope Proteins E1,Viral Envelope Proteins E2,Viral Envelope Proteins gp52,Viral Envelope Proteins gp70,Virus Envelope Proteins,Envelope Glycoproteins, Viral,Envelope Protein, Viral,Envelope Protein, Virus,Envelope Proteins, Virus,Glycoproteins, Viral Envelope,Peplomer Proteins, Virus,Protein, Viral Envelope,Protein, Virus Envelope,Proteins, Viral Envelope,Proteins, Virus Envelope,Proteins, Virus Peplomer
D014760 Viral Fusion Proteins Proteins, usually glycoproteins, found in the viral envelopes of a variety of viruses. They promote cell membrane fusion and thereby may function in the uptake of the virus by cells. Fusion Proteins, Viral,Viral Fusion Glycoproteins,F Protein (Sendai Virus),F Protein Measles Virus,F Protein Newcastle Disease Virus,F Protein SV,F-Glycoprotein SV,F1 Polypeptide (Paramyxovirus),Fusion Glycoprotein, Viral,Fusion VP1 Protein,Glycoprotein, Viral Fusion,Measles Fusion Protein,Mumps Virus Fusion Protein,Paramyxovirus Fusion Protein,Sendai Virus Fusion Protein,Viral Fusion-GP,Virus Fusion Proteins,Fusion Glycoproteins, Viral,Fusion Protein, Measles,Fusion Protein, Paramyxovirus,Fusion Proteins, Virus,Fusion-GP, Viral,Glycoproteins, Viral Fusion,Proteins, Virus Fusion,VP1 Protein, Fusion,Viral Fusion GP,Viral Fusion Glycoprotein
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D016679 Genome, Viral The complete genetic complement contained in a DNA or RNA molecule in a virus. Viral Genome,Genomes, Viral,Viral Genomes

Related Publications

H Garoff, and J Wilschut, and P Liljeström, and J M Wahlberg, and R Bron, and M Suomalainen, and J Smyth, and A Salminen, and B U Barth, and H Zhao
December 1984, Biochemical Society transactions,
H Garoff, and J Wilschut, and P Liljeström, and J M Wahlberg, and R Bron, and M Suomalainen, and J Smyth, and A Salminen, and B U Barth, and H Zhao
June 1967, Nature,
H Garoff, and J Wilschut, and P Liljeström, and J M Wahlberg, and R Bron, and M Suomalainen, and J Smyth, and A Salminen, and B U Barth, and H Zhao
April 1997, Virology,
H Garoff, and J Wilschut, and P Liljeström, and J M Wahlberg, and R Bron, and M Suomalainen, and J Smyth, and A Salminen, and B U Barth, and H Zhao
April 1979, Biochemical Society transactions,
H Garoff, and J Wilschut, and P Liljeström, and J M Wahlberg, and R Bron, and M Suomalainen, and J Smyth, and A Salminen, and B U Barth, and H Zhao
September 2000, Journal of virology,
H Garoff, and J Wilschut, and P Liljeström, and J M Wahlberg, and R Bron, and M Suomalainen, and J Smyth, and A Salminen, and B U Barth, and H Zhao
January 1945, California and western medicine,
H Garoff, and J Wilschut, and P Liljeström, and J M Wahlberg, and R Bron, and M Suomalainen, and J Smyth, and A Salminen, and B U Barth, and H Zhao
February 1980, The Journal of cell biology,
H Garoff, and J Wilschut, and P Liljeström, and J M Wahlberg, and R Bron, and M Suomalainen, and J Smyth, and A Salminen, and B U Barth, and H Zhao
August 1996, The Journal of cell biology,
H Garoff, and J Wilschut, and P Liljeström, and J M Wahlberg, and R Bron, and M Suomalainen, and J Smyth, and A Salminen, and B U Barth, and H Zhao
December 1991, Virology,
H Garoff, and J Wilschut, and P Liljeström, and J M Wahlberg, and R Bron, and M Suomalainen, and J Smyth, and A Salminen, and B U Barth, and H Zhao
October 1975, Medical biology,
Copied contents to your clipboard!